TiE Boston Angels

Activity from announced rounds

Activity in this selectionsimplyhealth-ventures-98030ada
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$15.1M
2 disclosed · full round size, not this investor’s share

By stage

Seed2

By primary sector

Biotech1
Hardware1

By country

United States2

Rounds

2 in this selection
Myrias Optics

Develops all-inorganic additive nanoimprint technology for wafer-level metaoptics and waveguides

$2.1MSeed 1
Role not disclosed
GelMEDIX

Develops regenerative therapies to restore vision by regenerating damaged retinal cells

$13MSeed
Role not disclosed